First, Break All the Rules: What the World's Greatest Managers Do Differently Hot Commodities : How Anyone Can Invest Profitably in the World's Best Market Blue Ocean Strategy: How to Create Uncontested Market Space and Make Competition Irrelevant The Sociopath Next Door: The Ruthless Versus the Rest of Us Delivered from Distraction : Getting the Most out of Life with Attention Deficit Disorder Power vs. Force: The Hidden Determinants of Human Behavior The Toyota Way: 14 Management Principles From The World's Greatest Manufacturer 11 Practice Tests for the New SAT and PSAT: With Free Access to Online Score Reports and More SAT Help Big Bang: The Origin Of The Universe

• Positron Emission Tomography in the Initial Staging of Esophageal Cancer .
• Objective  To assess the value of positron emission tomography (PET) compared with computed tomography (CT) in the initial staging of esophageal cancer. ...
• Prospective Evaluation of Positron Emission Tomography in the Preoperative Staging of Esophageal Carcinoma.
• Systematic Review of the Staging Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer.
• Pitfalls of Positive Findings in Staging Esophageal Cancer With F-18-Fluorodeoxyglucose Positron Emission Tomography.

• Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed Tomography.
• Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed Tomography .
• Background We compared the diagnostic accuracy of integrated positron-emission tomography (PET) and computed tomography (CT) with that of CT alone, that of PET alone, and that of conventional visual correlation of PET and CT in determining the stage of disease in non–small-cell lung cancer. ...
• Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography and Computed Tomography Scans. ...
• Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer. ...
• Seeking a Home for a PET, Part 3: Emerging Applications of Positron Emission Tomography Imaging in the Management of Patients With Lung Cancer. ...
• Accuracy of Whole-Body Dual-Modality Fluorine-18-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PET. ...
• Impact of Patient Weight and Emission Scan Duration on PET/CT Image Quality and Lesion Detectability. ...
• 18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging of Locally Advanced Breast Cancer. ...
• Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. ...
• Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis. ...

• Our sister company, Cantor Environmental Brokerage, won Best Broker in each of the NOx (Reclaim) and Emission Reduction Credits markets, and won the runner-up award for NOx.
• We have demand for Certified Emission Reductions, CERs. ...

• Inductively coupled plasma optical emission spectroscopy (ICP-OES or ICP-AES) is a major technique for elemental analysis. ...
• This ICP Laboratory of optical emission spectroscopy is part of The Spectroscopy Net, a free and open resource designed by Dr Richard Payling of Surface Analytical, for Spectroscopists everywhere and everyone interested in Spectroscopy. ...

• ASTER (Advanced Spaceborne Thermal Emission and Reflection Radiometer) is an imaging instrument  flying on Terra, a satellite launched in December 1999 as part of NASA's Earth Observing System (EOS). ...

• Positron Emission Mammographic Instrument: Initial Results1 .
• Performance characteristics of a positron emission mammographic (PEM) instrument were studied. ...
• Results of Preliminary Clinical Trials of the Positron Emission Mammography System PEM-I: A Dedicated Breast Imaging System Producing Glucose Metabolic Images Using FDG.

• Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose .
• Positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG) was performed in non-Hodgkin's lymphoma (NHL), which is known to be highly responsive to chemotherapy, but also yields variable treatment results to answer the following questions: (1) What is the extent and time course of changes in FDG utilization in response to chemotherapy? (2) Are the changes of FDG uptake at early time points of chemotherapy predictive for therapy outcome? (3) Which quantitative FDG parameter provides the most sensitive measures of initial tumor response? Dynamic PET scans were performed in 11 patients at baseline and 1 and 6 weeks after initiation of chemotherapy. ...
• Seeking a Home for a PET, Part 3: Emerging Applications of Positron Emission Tomography Imaging in the Management of Patients With Lung Cancer.
• Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease.
• Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
• Pitfalls of Positron Emission Tomography for Assessing Residual Mediastinal Mass After Chemotherapy for Hodgkin's Disease.
• Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ( 18F FDG) After First-Line Chemotherapy in Non-Hodgkin's Lymphoma: Is 18F FDG-PET a Valid Alternative to Conventional Diagnostic Methods?.

• spark-emission. ...

•   ABOUT ACOUSTIC EMISSION .
• Acoustic Emission News.

• Evaluation of Esophageal Cancer by Positron Emission Tomography .
• Background: A retrospective study was performed to determine the indications for positron emission tomography (PET) using 18F fluorodeoxyglucose (FDG) in patients with esophageal cancer, including those with early cancer, and to investigate whether the tumor-to-normal ratio (T/N ratio) could be used as a substitute for the standardized uptake value (SUV). ...
• Positron emission tomography (PET) using 18F fluorodeoxyglucose (FDG) has been applied to the diagnosis of cancer in various organs (1,2). ...
• In addition, it has been reported that the tumor-to-normal ratio (T/N ratio) evaluated using emission scans alone is correlated with the SUV (12). ...
• Clinical characteristics of 31 patients with esophageal cancer who underwent positron emission tomography before treatment .
• Clinical characteristics of five patients with suspected recurrence of esophageal cancer who underwent postoperative positron emission tomography .
• Forty-five minutes after administration of 260 MBq (7 mCi) of FDG, emission scanning was performed from the level of the pelvis to the maxilla for 7 min in each bed position. ...
• Oncological application of positron emission tomography with fluorine-18 fluorodeoxyglucose. ...
• Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. ...
• Role of positron emission tomography in staging esophageal cancer. ...
• Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. ...
• Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. ...
• Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer. ...
• Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro 18F -D-glucose. ...
• Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? Eur J Cancer 1995;31A:1924–7.
• Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case. ...

• Positron Emission Tomography for Basal Cell Carcinoma of the Head and Neck .
• Objective  To determine the ability of fluorodeoxyglucose F 18 positron emission tomography (FDG-PET) to image basal cell carcinoma (BCC). ...

• 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies .
• Positron emission tomography with 18F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies. ...
• Keywords: positron emission tomography; 18F-Fluoro-2-deoxyglucose.
• Abbreviations: PET, positron emission tomography; FDG, 18F-fluoro-2-deoxyglucose; CT, computed tomography; CEA, carcinoembryonic antigen.
• Technical advances in positron emission tomography (PET) instrumentation and algorithm implementation have facilitated high quality clinical whole body imaging. ...
• Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. ...
• Value of positron emission tomography with F-18 fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. ...
• The clinical application of positron emission tomography to colorectal cancer management. ...
• Positron emission tomography in colorectal cancer. ...
• Additional value of whole-body positron emission tomography with fluorine-18–2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. ...
• Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000;180:1–5. ...
• Evaluation of benign vs malignant hepatic lesions with positron emission tomography. ...
• Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). ...
• A prospective study of 2- 18F fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. ...
• Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. ...
• Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. ...

Do you have a great site about Emission? Is your Emission site listed here? Would you like a prefered placement of your site in this directory?

It's easy! First place, the HTML from the box below on your page that you would like listed in this directory.

Then use our link submission request with your name, your contact information, and the URL of your site that has a link to this directory. After we verify your link to us, we'll make sure your site stays in our directory, and we'll give it prefered placement here also.

Here is how to make a simple text link to us. Just copy the code in this box to your website:

We can also develop a custom Guide To The Internet for your site. Please request your own custom Guide To The Internet.